articleTop 10% cited

Thyroid Lobectomy for Papillary Thyroid Cancer: Long‐term Follow‐up Study of 1,088 Cases

World Journal of Surgery · 2013 · Vol. 38(1) · pp. 68–79

Kenichi Matsuzu✉(Shibuya (Japan))Kiminori Sugino(Shibuya (Japan))Katsuhiko Masudo(Yokohama City University)Mitsuji Nagahama(Ito Hospital)Wataru Kitagawa(Shibuya (Japan))Hiroshi Shibuyà(Ito Hospital)Keiko Ohkuwa(Shibuya (Japan))Takashi Uruno(Ito Hospital)Akifumi Suzuki(Ito Hospital)Syunsuke Magoshi(Ito Hospital)Junko Akaishi(Shibuya (Japan))Chie Masaki(Ito Hospital)Michikazu Kawano(Ito Hospital)Nobuyasu Suganuma(Yokohama City University Hospital)Yasushi Rino(Yokohama City University Hospital)Munetaka Masuda(Yokohama City University)Kaori Kameyama(Keio University Hospital)Hiroshi Takami(Ito Hospital)Koichi Ito(Shibuya (Japan))

View via DOI Publisher page

Abstract

The long-term clinical outcome of the PTC patients who had been treated by lobectomy without RAI ablation was excellent. Based on the above results, we concluded that lobectomy is a valid alternative to total thyroidectomy for the treatment of PTC patients who are younger than aged 45 years, whose tumor diameter is 40 mm or less, and who do not have clinical lymph node metastasis or extrathyroidal invasion.

Thyroid Cancer Diagnosis and Treatment Thyroid and Parathyroid Surgery Head and Neck AnomaliesMedicineCardiothoracic surgeryVascular surgeryAbdominal surgeryPapillary thyroid cancerCardiac surgeryThyroid cancerThyroidTerm (time)General surgery

MeSH terms

Thyroid Cancer, PapillaryAdolescentAdultAgedAged, 80 and overCarcinomaCarcinoma, PapillaryChildFemaleFollow-Up StudiesHumansMaleMiddle AgedNeoplasm Recurrence, LocalRetrospective Studies

Citations

330

FWCI

9.21

field-weighted impact

References

Percentile

98%

vs. same field & year

Citations per year

Cited by

Guidelines for the management of thyroid cancer